Overview

Psychotherapy and Pharmacotherapy in Dissociative Disorders

Status:
Unknown status
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this observational study is to measure the efficacy of a specific combined treatment (psychotherapy and pharmacotherapy) on patients with dissociative disorders, in terms of patients with a favorable outcome by means of the Dissociative Experiences Scale (DES).
Details
Lead Sponsor:
Espace Hogan
Treatments:
Citalopram
Dexetimide
Quetiapine Fumarate